Improving clinical translation in neuroscience research has always been a major challenge until now. There are many research collaborations happening in the neuroscience space today for neurodegenerative disorders research. The conference will focus on discussing the latest technologies in the preclinical, translational neuroscience space and also drawing the attention of the audience towards new innovations happening in translational neuroscience imaging. The conference further aims to bring in the experts from academia and industry together to discuss how to create new, more effective translational neuroscience drawing on novel technology and recent discoveries.
Learn from 20+ industry leading speakers who will be sharing their presentations on CNS drug discovery, Latest Optogenetic tools, kinematic techniques, Blood-Brain Barrier Proteomics and Non-Invasive electrical brain stimulation.
Case studies presented from leading technology collaborations, Interactive panel and breakout sessions along with Access to online presentations on-demand post-summit.
First ever conference on application of technology in developing neurological treatments.
Meet 100+ global heads of neuroscience from the industry and Academics.
CSOs, Directors, Heads, VP, Managers, Scientists, Principal from Pharmaceutical, Academics and Research Institutes working in Neuroscience/CNS drug discovery, Neurotechnology, Neuroimaging, Translational Imaging, Neurodegenerative diseases
5th Annual Neuroscience R&D Technologies Conference
will be held in London, UK
For any queries regarding the hotel booking please write to us at [email protected]
Hotel Booking Link
You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on [email protected]